We are currently investing in Menlo XIV, a new $450 million fund to invest primarily in early-stage consumer, enterprise, and life science technologies. Menlo’s $250M Opportunity Fund supports current and new portfolio companies at the inflection stage of growth, typically Series B to Series C. Menlo’s $15M Talent Fund is earmarked for seed-stage companies.
We typically invest up to $20 million in our main fund, and continue to support subsequent rounds. For later stage opportunities, we have the capacity to invest more than $30 million and are flexible enough to pay an active role at any stage of a company’s development. We pursue capital-efficient models with the potential to disrupt huge markets. Our Menlo Talent Fund is a seed financing strategy for promising founders and we make decisions in as little as 24 hours for investments under $250k.